In conclusion, in the majority of Ashkenazi Jewish families with an inherited predisposition to melanoma with or without NST, CDKN2A/ARF and CDK4 loci are unlikely to be implicated in the predisposition to melanoma and the associated neural system tumours. The gene discussed is CDKN2A; the disease is melanoma.